Back to Resource Library
Republished with permission of:Victoria EnglishEditor, MedNousLondon, UKDr. Peter Marks, Director for the Center for Biologics Evaluation and Research (CBER) of the US Food and Drug Administration, shared some perspectives from the FDA at ISCT 2021. In this piece by Victoria English, learn about some of the implications this might have for the global Gene Therapy field going forward.#Regulatory#28.3#28.3